SkylineDx  

3030 Bunker Hill street
Suite 201
San Diego,  CA  92109

United States
http://www.skylinedx.com
  • Booth: 1862

SkylineDx is a high-tech, commercial-stage biotech company headquartered in Rotterdam, The Netherlands and a commercial office with CAP/CLIA certified laboratory in San Diego, CA, USA. We use our expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility. Focused on diagnostics, SkylineDx assists healthcare professionals in accurately determining the type or status of the disease or to predict a patient’s response to a specific treatment. Based on the test results, healthcare professionals can tailor the treatment to the individual patient.


 Products

  • SKY92
    SKY92 is a clinical test used to aid physicians in the prognosis of Multiple Myeloma (blood cancer)....

  • Our lead product MMprofilerTM, is a clinical test used to aid physicians in the prognosis of multiple myeloma (blood cancer). It measures the activity of 92 cancer genes (SKY92), and is the most reliable test on the market to determine a patient’s prognosis. The MMprofilerTM with SKY92 is available as CE-IVD kit in Europe and as a CLIA validated Laboratory Developed Test (LDT) in the United States.

 
    • ASH Exposition Management
    • SPARGO, Inc.
    • Toll Free: (800) 564-4220
    • Phone: (703) 631-6200
    • Fax: (703) 563-2691
    • Email: ashexhibits@spargoinc.com